DESCRIPTION: You are invited to participate in a research study validating a new survey measuring exposure to media and journalism related to psychedelics. This study aims to validate a new measure so it can be used in clinical trials of psychedelic drugs. You will be asked to answer questions about your demographics and take a survey about the types of media or journalism you engage with and what you think about it.
TIME INVOLVEMENT: Your participation in this study will take approximately 10-15 minutes.
RISKS AND BENEFITS: The risks associated with this study are discomfort answering questions about psychedelic-related media and a confidentiality breach. Your data will be stored in HIPAA-compliant encrypted databases and locked. We cannot and do not guarantee or promise that you will receive any benefits from this study. The development of this survey will contribute to future research examining predictors of response to psychedelic treatments and the role of expectancy effects. Your decision whether or not to participate in this study will not affect your medical care.
PAYMENTS: You will not receive payment for your participation.
PARTICIPANT'S RIGHTS: If you have read this form and have decided to participate in this project, please understand your participation is voluntary and you have the right to withdraw your consent or discontinue participation at any time without penalty or loss of benefits to which you are otherwise entitled. The alternative is not to participate. You have the right to refuse to answer particular questions. The results of this research study may be presented at scientific or professional meetings or published in scientific journals. Your individual privacy will be maintained in all published and written data resulting from the study.
Identifiers might be removed from identifiable private information and, after such removal, the information could be used for future research studies or distributed to another investigator for future research studies without additional informed consent from you.
CONTACT INFORMATION:
Questions: If you have any questions, concerns or complaints about this research, its procedures, risks and benefits, contact the Protocol Director, Boris Heifets, MD at 937-877-2233.You should also contact them at any time if you feel you have been hurt by being a part of this study.
Independent Contact: If you are not satisfied with how this study is being conducted, or if you have any concerns, complaints, or general questions about the research or your rights as a participant, please contact the Stanford Institutional Review Board (IRB) to speak to someone independent of the research team at 650-723-5244 or toll free at 1-866-680-2906. You can also write to the Stanford IRB, Stanford University, 1705 El Camino Real, Palo Alto, CA 94306.
Please print a copy of this page for your records.
If you agree to participate in this research, please complete the questionnaire on the following page.